Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1162

1.

A pharmacogenetic study implicates NINJ2 in the response to Interferon-β in multiple sclerosis.

Peroni S, Sorosina M, Malhotra S, Clarelli F, Osiceanu AM, Ferrè L, Roostaei T, Rio J, Midaglia L, Villar LM, Álvarez-Cermeño JC, Guaschino C, Radaelli M, Citterio L, Lechner-Scott J, Spataro N, Navarro A, Martinelli V, Montalban X, Weiner HL, de Jager P, Comi G, Esposito F, Comabella M, Martinelli-Boneschi F.

Mult Scler. 2019 Jun 21:1352458519851428. doi: 10.1177/1352458519851428. [Epub ahead of print]

PMID:
31221001
2.

The impact of cervical spinal cord atrophy on quality of life in multiple sclerosis.

Zurawski J, Glanz BI, Healy BC, Tauhid S, Khalid F, Chitnis T, Weiner HL, Bakshi R.

J Neurol Sci. 2019 Apr 18;403:38-43. doi: 10.1016/j.jns.2019.04.023. [Epub ahead of print]

3.

Author Correction: Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39.

Takenaka MC, Gabriely G, Rothhammer V, Mascanfroni ID, Wheeler MA, Chao CC, Gutiérrez-Vázquez C, Kenison J, Tjon EC, Barroso A, Vandeventer T, de Lima KA, Rothweiler S, Mayo L, Ghannam S, Zandee S, Healy L, Sherr D, Farez MF, Prat A, Antel J, Reardon DA, Zhang H, Robson SC, Getz G, Weiner HL, Quintana FJ.

Nat Neurosci. 2019 Jun 13. doi: 10.1038/s41593-019-0446-8. [Epub ahead of print]

PMID:
31197266
4.

Beta-Catenin Mutation with Complex Chromosomal Changes in Desmoid Tumor of the Scalp: A Case Report.

Liu G, Weiner HL, Pederson WC, Davies L, Buchanan EP.

Craniomaxillofac Trauma Reconstr. 2019 Jun;12(2):146-149. doi: 10.1055/s-0038-1676078. Epub 2018 Nov 16.

PMID:
31073365
5.

Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39.

Takenaka MC, Gabriely G, Rothhammer V, Mascanfroni ID, Wheeler MA, Chao CC, Gutiérrez-Vázquez C, Kenison J, Tjon EC, Barroso A, Vandeventer T, de Lima KA, Rothweiler S, Mayo L, Ghannam S, Zandee S, Healy L, Sherr D, Farez MF, Prat A, Antel J, Reardon DA, Zhang H, Robson SC, Getz G, Weiner HL, Quintana FJ.

Nat Neurosci. 2019 May;22(5):729-740. doi: 10.1038/s41593-019-0370-y. Epub 2019 Apr 8. Erratum in: Nat Neurosci. 2019 Jun 13;:.

PMID:
30962630
6.

Pediatric Craniomaxillofacial Oncologic Reconstruction.

Dempsey RF, Chelius DC Jr, Pederson WC, Maricevich M, Dimachkieh AL, Kupferman ME, Weiner HL, Hollier LH Jr, Buchanan EP.

Clin Plast Surg. 2019 Apr;46(2):261-273. doi: 10.1016/j.cps.2018.11.011. Epub 2019 Jan 30. Review.

PMID:
30851757
7.

Cross-sectional study of smoking exposure: no differential effect on OCT metrics in a cohort of MS patients.

Rosso M, Kimbrough DJ, Gonzalez CT, Glanz BI, Healy BC, Rocca MA, Filippi M, Weiner H, Chitnis T.

Mult Scler J Exp Transl Clin. 2019 Feb 25;5(1):2055217319828400. doi: 10.1177/2055217319828400. eCollection 2019 Jan-Mar.

8.

MRI phenotypes in MS: Longitudinal changes and miRNA signatures.

Hemond CC, Healy BC, Tauhid S, Mazzola MA, Quintana FJ, Gandhi R, Weiner HL, Bakshi R.

Neurol Neuroimmunol Neuroinflamm. 2019 Feb 14;6(2):e530. doi: 10.1212/NXI.0000000000000530. eCollection 2019 Mar.

9.

Time between expanded disability status scale (EDSS) scores.

Zurawski J, Glanz BI, Chua A, Lokhande H, Rotstein D, Weiner H, Engler D, Chitnis T, Healy BC.

Mult Scler Relat Disord. 2019 May;30:98-103. doi: 10.1016/j.msard.2019.02.007. Epub 2019 Feb 5.

PMID:
30763908
10.

Analysis of metabolic flux in felid spermatozoa using metabolomics and 13C-based fluxomics†.

Weiner HS, Crosier AE, Keefer CL.

Biol Reprod. 2019 May 1;100(5):1261-1274. doi: 10.1093/biolre/ioz010.

PMID:
30715249
11.

Neurofilament light chain serum levels correlate with 10-year MRI outcomes in multiple sclerosis.

Chitnis T, Gonzalez C, Healy BC, Saxena S, Rosso M, Barro C, Michalak Z, Paul A, Kivisakk P, Diaz-Cruz C, Sattarnezhad N, Pierre IV, Glanz BI, Tomic D, Kropshofer H, Häring D, Leppert D, Kappos L, Bakshi R, Weiner HL, Kuhle J.

Ann Clin Transl Neurol. 2018 Oct 16;5(12):1478-1491. doi: 10.1002/acn3.638. eCollection 2018 Dec.

12.

Food allergies are associated with increased disease activity in multiple sclerosis.

Fakih R, Diaz-Cruz C, Chua AS, Gonzalez C, Healy BC, Sattarnezhad N, Glanz BI, Weiner HL, Chitnis T.

J Neurol Neurosurg Psychiatry. 2019 Jun;90(6):629-635. doi: 10.1136/jnnp-2018-319301. Epub 2018 Dec 18.

PMID:
30563943
13.

Publisher Correction: An immunoregulatory and tissue-residency program modulated by c-MAF in human TH17 cells.

Aschenbrenner D, Foglierini M, Jarrossay D, Hu D, Weiner HL, Kuchroo VK, Lanzavecchia A, Notarbartolo S, Sallusto F.

Nat Immunol. 2019 Jan;20(1):109. doi: 10.1038/s41590-018-0264-2.

PMID:
30448856
14.

Acute microglia ablation induces neurodegeneration in the somatosensory system.

Rubino SJ, Mayo L, Wimmer I, Siedler V, Brunner F, Hametner S, Madi A, Lanser A, Moreira T, Donnelly D, Cox L, Rezende RM, Butovsky O, Lassmann H, Weiner HL.

Nat Commun. 2018 Nov 1;9(1):4578. doi: 10.1038/s41467-018-05929-4.

15.

Invasive monitoring after resection of epileptogenic neocortical lesions in multistaged epilepsy surgery in children.

Hidalgo ET, Frankel HG, Rodriguez C, Orillac C, Phillips S, Patel N, Devinsky O, Friedman D, Weiner HL.

Epilepsy Res. 2018 Dec;148:48-54. doi: 10.1016/j.eplepsyres.2018.09.001. Epub 2018 Sep 19.

PMID:
30384114
16.

Assessment of computer adaptive testing version of the Neuro-QOL for people with multiple sclerosis.

Healy BC, Zurawski J, Gonzalez CT, Chitnis T, Weiner HL, Glanz BI.

Mult Scler. 2018 Nov 1:1352458518810159. doi: 10.1177/1352458518810159. [Epub ahead of print]

PMID:
30381985
17.

Epilepsy surgery in Panama: Establishment of a successful hybrid program as a model for small middle-income countries.

Kuzniecky R, Baez C, Aranda G, Hidalgo ET, Grover A, Orillac C, Zelenka Y, Weiner HL.

Epilepsia. 2018 Nov;59(11):2137-2144. doi: 10.1111/epi.14571. Epub 2018 Oct 19.

PMID:
30338512
18.

Infection risk with alemtuzumab decreases over time: pooled analysis of 6-year data from the CAMMS223, CARE-MS I, and CARE-MS II studies and the CAMMS03409 extension study.

Wray S, Havrdova E, Snydman DR, Arnold DL, Cohen JA, Coles AJ, Hartung HP, Selmaj KW, Weiner HL, Daizadeh N, Margolin DH, Chirieac MC, Compston DAS.

Mult Scler. 2018 Oct 5:1352458518796675. doi: 10.1177/1352458518796675. [Epub ahead of print]

PMID:
30289355
19.

CLA-supplemented diet accelerates experimental colorectal cancer by inducing TGF-β-producing macrophages and T cells.

Moreira TG, Horta LS, Gomes-Santos AC, Oliveira RP, Queiroz NMGP, Mangani D, Daniel B, Vieira AT, Liu S, Rodrigues AM, Gomes DA, Gabriely G, Ferreira E, Weiner HL, Rezende RM, Nagy L, Faria AMC.

Mucosal Immunol. 2019 Jan;12(1):188-199. doi: 10.1038/s41385-018-0090-8. Epub 2018 Oct 2.

PMID:
30279515
20.

Long-term follow-up for multiple sclerosis patients initially treated with interferon-beta and glatiramer acetate.

Healy BC, Glanz BI, Zurawski JD, Mazzola M, Chitnis T, Weiner HL.

J Neurol Sci. 2018 Nov 15;394:127-131. doi: 10.1016/j.jns.2018.09.020. Epub 2018 Sep 17.

PMID:
30248571
21.

Central nervous system manifestations of tuberous sclerosis complex.

Lu DS, Karas PJ, Krueger DA, Weiner HL.

Am J Med Genet C Semin Med Genet. 2018 Sep;178(3):291-298. doi: 10.1002/ajmg.c.31647. Epub 2018 Sep 19. Review.

PMID:
30230171
22.

Brain and spinal cord MRI lesions in primary progressive vs. relapsing-remitting multiple sclerosis.

Dastagir A, Healy BC, Chua AS, Chitnis T, Weiner HL, Bakshi R, Tauhid S.

eNeurologicalSci. 2018 Jul 4;12:42-46. doi: 10.1016/j.ensci.2018.07.002. eCollection 2018 Sep.

23.

Microglial signatures and their role in health and disease.

Butovsky O, Weiner HL.

Nat Rev Neurosci. 2018 Oct;19(10):622-635. doi: 10.1038/s41583-018-0057-5. Review.

PMID:
30206328
24.

An immunoregulatory and tissue-residency program modulated by c-MAF in human TH17 cells.

Aschenbrenner D, Foglierini M, Jarrossay D, Hu D, Weiner HL, Kuchroo VK, Lanzavecchia A, Notarbartolo S, Sallusto F.

Nat Immunol. 2018 Oct;19(10):1126-1136. doi: 10.1038/s41590-018-0200-5. Epub 2018 Sep 10. Erratum in: Nat Immunol. 2019 Jan;20(1):109.

25.

Identification of MS-specific serum miRNAs in an international multicenter study.

Regev K, Healy BC, Paul A, Diaz-Cruz C, Mazzola MA, Raheja R, Glanz BI, Kivisäkk P, Chitnis T, Jagodic M, Piehl F, Olsson T, Khademi M, Hauser S, Oksenberg J, Khoury SJ, Weiner HL, Gandhi R.

Neurol Neuroimmunol Neuroinflamm. 2018 Aug 20;5(5):e491. doi: 10.1212/NXI.0000000000000491. eCollection 2018 Sep.

26.

γδ T cells control humoral immune response by inducing T follicular helper cell differentiation.

Rezende RM, Lanser AJ, Rubino S, Kuhn C, Skillin N, Moreira TG, Liu S, Gabriely G, David BA, Menezes GB, Weiner HL.

Nat Commun. 2018 Aug 8;9(1):3151. doi: 10.1038/s41467-018-05487-9.

27.

18F-PBR06 Versus 11C-PBR28 PET for Assessing White Matter Translocator Protein Binding in Multiple Sclerosis.

Singhal T, OʼConnor K, Dubey S, Belanger AP, Hurwitz S, Chu R, Tauhid S, Kijewski MF, DiCarli MF, Weiner HL, Bakshi R.

Clin Nucl Med. 2018 Sep;43(9):e289-e295. doi: 10.1097/RLU.0000000000002179.

PMID:
30004939
28.

Cellular Components and Mechanisms of Oral Tolerance Induction.

Rezende RM, Weiner HL.

Crit Rev Immunol. 2018;38(3):207-231. doi: 10.1615/CritRevImmunol.2018026181.

PMID:
30004858
29.

Microglia inhibit photoreceptor cell death and regulate immune cell infiltration in response to retinal detachment.

Okunuki Y, Mukai R, Pearsall EA, Klokman G, Husain D, Park DH, Korobkina E, Weiner HL, Butovsky O, Ksander BR, Miller JW, Connor KM.

Proc Natl Acad Sci U S A. 2018 Jul 3;115(27):E6264-E6273. doi: 10.1073/pnas.1719601115. Epub 2018 Jun 18.

30.

Short Report: A Pilot Study of a Group Positive Psychology Intervention for Patients with Multiple Sclerosis.

Leclaire K, Cecil A, LaRussa A, Stuart F, Hemond CC, Healy BC, Chitnis T, Weiner H, Huffman J, Glanz BI.

Int J MS Care. 2018 May-Jun;20(3):136-141. doi: 10.7224/1537-2073.2017-002.

31.

Pro-inflammatory activation of microglia in the brain of patients with sepsis.

Zrzavy T, Höftberger R, Berger T, Rauschka H, Butovsky O, Weiner H, Lassmann H.

Neuropathol Appl Neurobiol. 2019 Apr;45(3):278-290. doi: 10.1111/nan.12502. Epub 2018 Jun 19.

32.

A probiotic modulates the microbiome and immunity in multiple sclerosis.

Tankou SK, Regev K, Healy BC, Tjon E, Laghi L, Cox LM, Kivisäkk P, Pierre IV, Hrishikesh L, Gandhi R, Cook S, Glanz B, Stankiewicz J, Weiner HL.

Ann Neurol. 2018 Jun;83(6):1147-1161. doi: 10.1002/ana.25244. Epub 2018 Jun 8.

33.

Systematic evaluation of RNA quality, microarray data reliability and pathway analysis in fresh, fresh frozen and formalin-fixed paraffin-embedded tissue samples.

Wimmer I, Tröscher AR, Brunner F, Rubino SJ, Bien CG, Weiner HL, Lassmann H, Bauer J.

Sci Rep. 2018 Apr 20;8(1):6351. doi: 10.1038/s41598-018-24781-6.

34.

Brain atrophy and disability worsening in primary progressive multiple sclerosis: insights from the INFORMS study.

Miller DH, Lublin FD, Sormani MP, Kappos L, Yaldizli Ö, Freedman MS, Cree BAC, Weiner HL, Lubetzki C, Hartung HP, Montalban X, Uitdehaag BMJ, MacManus DG, Yousry TA, Gandini Wheeler-Kingshott CAM, Li B, Putzki N, Merschhemke M, Häring DA, Wolinsky JS.

Ann Clin Transl Neurol. 2018 Jan 30;5(3):346-356. doi: 10.1002/acn3.534. eCollection 2018 Mar.

35.

Multiple Sclerosis: Mechanisms and Immunotherapy.

Baecher-Allan C, Kaskow BJ, Weiner HL.

Neuron. 2018 Feb 21;97(4):742-768. doi: 10.1016/j.neuron.2018.01.021. Review.

36.

Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosis.

Raheja R, Regev K, Healy BC, Mazzola MA, Beynon V, Von Glehn F, Paul A, Diaz-Cruz C, Gholipour T, Glanz BI, Kivisakk P, Chitnis T, Weiner HL, Berry JD, Gandhi R.

Muscle Nerve. 2018 Aug;58(2):261-269. doi: 10.1002/mus.26106. Epub 2018 Mar 25.

PMID:
29466830
37.

Long-Term Outcome and Secondary Operations after Proximal Row Carpectomy or Four-Corner Arthrodesis.

Williams JB, Weiner H, Tyser AR.

J Wrist Surg. 2018 Feb;7(1):51-56. doi: 10.1055/s-0037-1604395. Epub 2017 Jul 27.

38.

Microbiota Signaling Pathways that Influence Neurologic Disease.

Cox LM, Weiner HL.

Neurotherapeutics. 2018 Jan;15(1):135-145. doi: 10.1007/s13311-017-0598-8. Review.

39.

Investigation of probiotics in multiple sclerosis.

Tankou SK, Regev K, Healy BC, Cox LM, Tjon E, Kivisakk P, Vanande IP, Cook S, Gandhi R, Glanz B, Stankiewicz J, Weiner HL.

Mult Scler. 2018 Jan;24(1):58-63. doi: 10.1177/1352458517737390. Erratum in: Mult Scler. 2019 Jan;25(1):176.

PMID:
29307299
40.

A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia.

Wang AY, Weiner H, Green M, Chang H, Fulton N, Larson RA, Odenike O, Artz AS, Bishop MR, Godley LA, Thirman MJ, Kosuri S, Churpek JE, Curran E, Pettit K, Stock W, Liu H.

J Hematol Oncol. 2018 Jan 5;11(1):4. doi: 10.1186/s13045-017-0550-8.

41.

Predictors of hematological abnormalities in multiple sclerosis patients treated with fingolimod and dimethyl fumarate and impact of treatment switch on lymphocyte and leukocyte count.

Baharnoori M, Gonzalez CT, Chua A, Diaz-Cruz C, Healy BC, Stankiewicz J, Weiner HL, Chitnis T.

Mult Scler Relat Disord. 2018 Feb;20:51-57. doi: 10.1016/j.msard.2017.12.003. Epub 2017 Dec 14.

PMID:
29304497
42.

Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL.

Kadri S, Lee J, Fitzpatrick C, Galanina N, Sukhanova M, Venkataraman G, Sharma S, Long B, Petras K, Theissen M, Ming M, Kobzev Y, Kang W, Guo A, Wang W, Niu N, Weiner H, Thirman M, Stock W, Smith SM, Nabhan C, Segal JP, Lu P, Wang YL.

Blood Adv. 2017 May 2;1(12):715-727. doi: 10.1182/bloodadvances.2016003632. eCollection 2017 May 9.

43.

Dual-Sensitivity Multiple Sclerosis Lesion and CSF Segmentation for Multichannel 3T Brain MRI.

Meier DS, Guttmann CRG, Tummala S, Moscufo N, Cavallari M, Tauhid S, Bakshi R, Weiner HL.

J Neuroimaging. 2018 Jan;28(1):36-47. doi: 10.1111/jon.12491. Epub 2017 Dec 13.

44.

Resection of a Pediatric Thalamic Juvenile Pilocytic Astrocytoma with Whole Brain Tractography.

Weiner HL, Placantonakis DG.

Cureus. 2017 Oct 11;9(10):e1768. doi: 10.7759/cureus.1768.

45.

Dominant role of microglial and macrophage innate immune responses in human ischemic infarcts.

Zrzavy T, Machado-Santos J, Christine S, Baumgartner C, Weiner HL, Butovsky O, Lassmann H.

Brain Pathol. 2018 Nov;28(6):791-805. doi: 10.1111/bpa.12583. Epub 2017 Dec 28.

46.

TSPO-PET Imaging to Assess Cerebral Microglial Activation in Multiple Sclerosis.

Singhal T, Weiner HL, Bakshi R.

Semin Neurol. 2017 Oct;37(5):546-557. doi: 10.1055/s-0037-1608715. Epub 2017 Dec 5. Review. No abstract available.

PMID:
29207414
47.

Transcriptional signature of human pro-inflammatory TH17 cells identifies reduced IL10 gene expression in multiple sclerosis.

Hu D, Notarbartolo S, Croonenborghs T, Patel B, Cialic R, Yang TH, Aschenbrenner D, Andersson KM, Gattorno M, Pham M, Kivisakk P, Pierre IV, Lee Y, Kiani K, Bokarewa M, Tjon E, Pochet N, Sallusto F, Kuchroo VK, Weiner HL.

Nat Commun. 2017 Nov 17;8(1):1600. doi: 10.1038/s41467-017-01571-8.

48.

A two-year study using cerebral gray matter volume to assess the response to fingolimod therapy in multiple sclerosis.

Yousuf F, Dupuy SL, Tauhid S, Chu R, Kim G, Tummala S, Khalid F, Weiner HL, Chitnis T, Healy BC, Bakshi R.

J Neurol Sci. 2017 Dec 15;383:221-229. doi: 10.1016/j.jns.2017.10.019. Epub 2017 Oct 16.

49.

Treatment satisfaction across injectable, infusion, and oral disease-modifying therapies for multiple sclerosis.

Eagle T, Stuart F, Chua AS, LaRussa A, Leclaire K, Cook SL, Chitnis T, Weiner HL, Glanz BI, Healy BC.

Mult Scler Relat Disord. 2017 Nov;18:196-201. doi: 10.1016/j.msard.2017.10.002. Epub 2017 Oct 5.

PMID:
29141809
50.

Monomethyl fumarate treatment impairs maturation of human myeloid dendritic cells and their ability to activate T cells.

Mazzola MA, Raheja R, Regev K, Beynon V, von Glehn F, Paul A, Pierre I, Kivisakk P, Weiner HL, Gandhi R.

Mult Scler. 2019 Jan;25(1):63-71. doi: 10.1177/1352458517740213. Epub 2017 Nov 6.

PMID:
29106333

Supplemental Content

Loading ...
Support Center